[1] |
Djurdjevic D, Lengemann FW. Effect of perchlorate on the milk-plasma radioiodine ratio of intact and thyroidectomized goats[J]. J Dairy Sci, 1970, 53:808-812.
|
[2] |
Zhang Y. Lactation medication guide[J]. World Health Digest, 2009, 6(20):10.
|
[3] |
Atkinson HC, Begg EJ. Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics[J]. Br J Clin Pharmacol, 1988, 25:495-503.
|
[4] |
Berlin CM, Briggs GG. Drugs and chemicals in human milk[J]. Semin Fetal Neonatal Med, 2005, 10:149-159.
|
[5] |
Gentile S, Rossi A, Bellantuono C. SSRIs during breastfeeding: Spotlight on milk-to-plasma ratio[J]. Arch Womens Ment Health, 2007, 10:39-51.
|
[6] |
Fatemi MH, Ghorbanzad'e M. Classification of drugs according to their milk/plasma concentration ratio[J]. Eur J Med Chem, 45:5051-5055.
|
[7] |
Ansell C, Moore A, Barrie H. Electrolyte pH changes in human milk[J]. Pediatr Res, 1977, 11:1177-1179.
|
[8] |
Atkinson HC, Begg EJ. Prediction of drug distribution into human milk from physicochemical characteristics[J]. Clin Pharmacokinet, 1990, 18:151-167.
|
[9] |
Bailey DN, Briggs JR. The binding of acetaminophen, lidocaine, and valproic acid to human milk[J]. Am J Clin Pathol, 2004, 121:754-757.
|
[10] |
Matthew PD, Sharon JG, Evan JB. Comment: Prediction of milk/plasma concentration ratio of drugs[J]. Ann Pharmacother, 2004(38):174-175.
|
[11] |
Pons G, Schoerlin MP, Tam YK, et al. Moclobemide excretion in human breast milk[J]. Br J Clin Pharmacol, 1990, 29:27-31.
|
[12] |
Bright SA, Schultze WD, Paape MJ, et al. Effect of intramammary devices on the outcome of induced Escherichia coli infection of bovine mammary quarters[J]. Am J Vet Res, 1987, 48:1290-1294.
|
[13] |
Feibus KB. FDA's proposed rule for pregnancy and lactation labeling: Improving maternal child health through well-informed medicine use[J]. J Med Toxicol, 2008, 4:284-288.
|
[14] |
Moscandrew M, Kane S. Inflammatory bowel diseases and management considerations: Fertility and pregnancy[J]. Curr Gastroenterol Rep, 2009, 11:395-399.
|
[15] |
Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: A review of the evidence[J]. Pediatrics, 2009, 124:e547-556.
|
[16] |
Cipriani A, Geddes JR, Furukawa TA, et al. Meta review on short-term effectiveness and safety of antidepressants for depression: An evidence-based approach to inform clinical practice[J]. Can J Psychiatry, 2007, 52:553-562.
|
[17] |
Anderson PO, Valdes V. A critical review of pharmaceutical galactagogues[J]. Breastfeed Med, 2007, 2:229-242.
|
[18] |
International Commission on Radiological Protection. Release of patients after therapy with unsealed radionuclides[J]. Ann ICRP, 2004, 34(2):v-vi, 1-79.
|
[19] |
Jayawickrama HS, Amir LH, Pirotta MV. GPs' decision-making when prescribing medicines for breastfeeding women: Content analysis of a survey[J]. BMC Res Notes, 2010, 3:82.
|
[20] |
Einarson A, Lawrimore T, Brand P, et al. Attitudes and practices of physicians and naturopaths toward herbal products, including use during pregnancy and lactation[J]. Can J Clin Pharmacol, 2000, 7:45-49.
|
[21] |
Chuang CH, Chang PJ, Hsieh WS, et al. Chinese herbal medicine use in Taiwan during pregnancy and the postpartum period: A population-based cohort study[J]. Int J Nurs Stud, 2009, 46:787-795.
|
[22] |
Lassanova M, Tisonova J, Bozekova L, et al. Drug information center[J]. Bratisl Lek Listy, 2001, 102:305-306.
|